ASX - By Stock
|
PCK |
Re:
Ann: SPP & shareholder update webinar
|
|
Maybloomer
|
55 |
15K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
55
|
15K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Maybloomer
|
510 |
148K |
9 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
510
|
148K
|
9
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Underwritten Share Purchase Plan to raise AUD $2.5 million
|
|
Maybloomer
|
40 |
11K |
3 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
40
|
11K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Maybloomer
|
59 |
15K |
4 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
59
|
15K
|
4
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Maybloomer
|
59 |
15K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
59
|
15K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Maybloomer
|
380 |
124K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
124K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Resubmission of NDA for Sofdra Completed
|
|
Maybloomer
|
108 |
26K |
6 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
108
|
26K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
13 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
1.5K
|
531K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Presentation
|
|
Maybloomer
|
62 |
19K |
21 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
62
|
19K
|
21
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Maybloomer
|
40 |
12K |
5 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
40
|
12K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Maybloomer
|
40 |
12K |
5 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
40
|
12K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Maybloomer
|
40 |
12K |
13 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
40
|
12K
|
13
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Investor Webinar Presentation
|
|
Maybloomer
|
5 |
1.8K |
5 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
5
|
1.8K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
7 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
1.5K
|
531K
|
7
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
3 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
1.5K
|
531K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
5 |
08/10/23 |
08/10/23 |
ASX - By Stock
|
1.5K
|
531K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
Maybloomer
|
20K |
16M |
10 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
20K
|
16M
|
10
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
20 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
1.5K
|
531K
|
20
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation- FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
68 |
15K |
2 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
68
|
15K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
New Hartley Analyst report on Bot
|
|
Maybloomer
|
93 |
27K |
4 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
93
|
27K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Maybloomer
|
7.7K |
2.8M |
1 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
7.7K
|
2.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Maybloomer
|
574 |
189K |
18 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
574
|
189K
|
18
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
293 |
70K |
14 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
293
|
70K
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
293 |
70K |
15 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
293
|
70K
|
15
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
293 |
70K |
7 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
293
|
70K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
293 |
70K |
4 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
293
|
70K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
293 |
70K |
5 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
293
|
70K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
293 |
70K |
5 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
293
|
70K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
11 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
1.5K
|
531K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
Maybloomer
|
60 |
24K |
3 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
24K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Maybloomer
|
150 |
61K |
2 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
150
|
61K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Maybloomer
|
1.0K |
386K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
386K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Maybloomer
|
17K |
6.5M |
5 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
17K
|
6.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
Maybloomer
|
111 |
40K |
8 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
111
|
40K
|
8
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
18 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
1.5K
|
531K
|
18
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
6 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
1.5K
|
531K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
5 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
1.5K
|
531K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Maybloomer
|
576 |
201K |
21 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
576
|
201K
|
21
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.5K |
531K |
16 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
1.5K
|
531K
|
16
|
|
ASX - By Stock
|
PCK |
Re:
Ann: PCK receives funding for 12 month pilot in Welsh care homes
|
|
Maybloomer
|
27 |
8.0K |
6 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
27
|
8.0K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Offer Booklet
|
|
Maybloomer
|
45 |
14K |
10 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
45
|
14K
|
10
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Offer Booklet
|
|
Maybloomer
|
45 |
14K |
3 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
45
|
14K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Maybloomer
|
190 |
61K |
11 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
190
|
61K
|
11
|
|
ASX - By Stock
|
FRE |
Re:
Nasal Spray
|
|
Maybloomer
|
87 |
56K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
87
|
56K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Who is ready for that 55% surge?
|
|
Maybloomer
|
44 |
11K |
5 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
44
|
11K
|
5
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Pause in Trading
|
|
Maybloomer
|
152 |
63K |
6 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
152
|
63K
|
6
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Prospectus - Bonus Options
|
|
Maybloomer
|
106 |
57K |
2 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
106
|
57K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Prospectus - Bonus Options
|
|
Maybloomer
|
106 |
57K |
0 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
106
|
57K
|
0
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
Maybloomer
|
20K |
16M |
11 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
20K
|
16M
|
11
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Creso's Second Consecutive Quarter of Record Revenue Growth
|
|
Maybloomer
|
389 |
59K |
3 |
04/07/21 |
04/07/21 |
ASX - By Stock
|
389
|
59K
|
3
|
|